Switch to:
GuruFocus has detected 2 Warning Signs with Allergan PLC $AGN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Allergan PLC (NYSE:AGN)
Cash Flow from Financing
$-25,122 Mil (TTM As of Dec. 2016)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2016, Allergan PLC paid $12,318 Mil more to buy back shares than it received from issuing new shares. It spent $18 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $70 Mil paying cash dividends to shareholders. It spent $56 Mil on other financial activities. In all, Allergan PLC spent $12,461 Mil on financial activities for the three months ended in Dec. 2016.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Allergan PLC's Cash from Financing for the fiscal year that ended in Dec. 2016 is calculated as:

Cash from Financing(A: Dec. 2016 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-15076.4+-9798.7+0+-278.4+31.4
=-25,122

Allergan PLC's Cash from Financing for the quarter that ended in Dec. 2016 is

Cash from Financing(Q: Dec. 2016 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-12317.8+-17.7+0+-69.6+-55.5
=-12,461

Allergan PLC Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2016 was -5.1 (Mar. 2016 ) + -3061.6 (Jun. 2016 ) + -9594.8 (Sep. 2016 ) + -12460.6 (Dec. 2016 ) = $-25,122 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Allergan PLC's net issuance of stock for the three months ended in Dec. 2016 was $-12,318 Mil. Allergan PLC paid $12,318 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Allergan PLC's net issuance of debt for the three months ended in Dec. 2016 was $-18 Mil. Allergan PLC spent $18 Mil paying down its debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Allergan PLC's net issuance of preferred for the three months ended in Dec. 2016 was $0 Mil. Allergan PLC paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Allergan PLC's cash flow for dividends for the three months ended in Dec. 2016 was $-70 Mil. Allergan PLC spent $70 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Allergan PLC's other financing for the three months ended in Dec. 2016 was $-56 Mil. Allergan PLC spent $56 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Allergan PLC Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Net Issuance of Stock 148304841-16-170-1303,953-15,076
Net Issuance of Debt -327-28323-460-295,3612,4373,22925,004-9,799
Net Issuance of Preferred 000000004,9300
Dividends 00000000-208-278
Other Financing 000-05-155-3,135-82-23531
Cash from Financing -313-20353-411165,190-8673,01833,443-25,122

Allergan PLC Quarterly Data

Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16
Net Issuance of Stock -40-304,007-37-7-10-53-14-2,691-12,318
Net Issuance of Debt 4,400-4,92729,266-4,023-231-8900-3,836-6,845-18
Net Issuance of Preferred 004,9300000000
Dividends 000-69-70-70-70-70-70-70
Other Financing -4,3844,799-2,9172,65859-36-78285812-56
Cash from Financing -24-15935,286-1,471-248-123-5-3,062-9,595-12,461
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK